| HUman MicroNucleus project: international database comparison for results with the cytokinesis‐block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol … S Bonassi, M Fenech, C Lando, Y Lin, M Ceppi, WP Chang, N Holland, ... Environmental and molecular mutagenesis 37 (1), 31-45, 2001 | 576 | 2001 |
| The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes F Bellora, R Castriconi, A Dondero, G Reggiardo, L Moretta, A Mantovani, ... Proceedings of the National Academy of Sciences 107 (50), 21659-21664, 2010 | 252 | 2010 |
| Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. F Merlo, A Andreassen, A Weston, CF Pan, A Haugen, F Valerio, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1998 | 170 | 1998 |
| Efficacy of ranolazine in patients with symptomatic hypertrophic cardiomyopathy: the RESTYLE-HCM randomized, double-blind, placebo-controlled study I Olivotto, PG Camici, PA Merlini, C Rapezzi, M Patten, V Climent, ... Circulation: Heart Failure 11 (1), e004124, 2018 | 127 | 2018 |
| A historical cohort mortality study among shipyard workers in Genoa, Italy R Puntoni, F Merlo, L Borsa, G Reggiardo, E Garrone, M Ceppi American journal of industrial medicine 40 (4), 363-370, 2001 | 95 | 2001 |
| Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma G Cangemi, G Reggiardo, S Barco, L Barbagallo, M Conte, P D’Angelo, ... OncoTargets and therapy, 417-423, 2012 | 86 | 2012 |
| The IgE repertoire in children and adolescents resolved at component level: a cross‐sectional study G Melioli, L Marcomini, A Agazzi, G Bazurro, M Tosca, GA Rossi, P Minale, ... Pediatric allergy and immunology 23 (5), 433-440, 2012 | 81 | 2012 |
| Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma S Barco, I Gennai, G Reggiardo, B Galleni, L Barbagallo, A Maffia, ... Clinical biochemistry 47 (9), 848-852, 2014 | 78 | 2014 |
| Lung cancer risk among refractory brick workers exposed to crystalline silica: a retrospective cohort study F Merlo, M Costantini, G Reggiardo, M Ceppi, R Puntoni Epidemiology 2 (4), 299-304, 1991 | 69 | 1991 |
| Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival G Rosati, R Chiacchio, G Reggiardo, D De Sanctis, L Manzione Tumor Biology 25 (5-6), 258-263, 2004 | 67 | 2004 |
| Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study G Rosati, S Cordio, R Bordonaro, G Caputo, G Novello, G Reggiardo, ... Annals of oncology 21 (4), 781-786, 2010 | 55 | 2010 |
| Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre … A Maggio, A Kattamis, M Felisi, G Reggiardo, A El-Beshlawy, M Bejaoui, ... The Lancet Haematology 7 (6), e469-e478, 2020 | 53 | 2020 |
| Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients G Rosati, S Cordio, A Tucci, G Blanco, R Bordonaro, G Reggiardo, ... Oncology 69 (2), 122-129, 2005 | 45 | 2005 |
| The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate F Braido, G Schenone, E Pallestrini, G Reggiardo, G Cangemi, ... J Biol Regul Homeost Agents 25 (3), 477-485, 2011 | 42 | 2011 |
| Allergenius, an expert system for the interpretation of allergen microarray results G Melioli, C Spenser, G Reggiardo, G Passalacqua, E Compalati, ... World Allergy Organization Journal 7, 15, 2014 | 39 | 2014 |
| XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study G Rosati, A Avallone, G Aprile, A Butera, G Reggiardo, D Bilancia Cancer chemotherapy and pharmacology 71, 257-264, 2013 | 35 | 2013 |
| Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study G Rosati, D Bilancia, D Germano, A Dinota, R Romano, G Reggiardo, ... Annals of oncology 18, vi128-vi132, 2007 | 35 | 2007 |
| Paediatric medicines in Europe: the paediatric regulation—is it time for reform? M Toma, M Felisi, D Bonifazi, F Bonifazi, V Giannuzzi, G Reggiardo, ... Frontiers in medicine 8, 593281, 2021 | 29 | 2021 |
| Early diastolic dysfunction after cancer chemotherapy: primary endpoint results of a multicenter cardio-oncology study V Calabrese, P Menna, O Annibali, G Armento, A Carpino, E Cerchiara, ... Chemotherapy 63 (2), 55-63, 2018 | 29 | 2018 |
| Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study. G Rosati, A Rossi, D Germano, G Reggiardo, L Manzione Anticancer research 23 (3C), 2981-2985, 2003 | 29 | 2003 |
Borghi ClaudioProfessor of Medicine-University of Bologna, Bologna-ItalyVerified email at unibo.it
